[96a5a0]: / output / allTrials / identified / NCT00254891_identified.json

Download this file

219 lines (219 with data), 9.1 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
{
"info": {
"nct_id": "NCT00254891",
"official_title": "International, Randomized, Open-Label, Phase 3 Trial of Paclitaxel/Carboplatin Plus PF-3512676 Versus Paclitaxel/Carboplatin Alone as First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer",
"inclusion_criteria": "* Advanced Non-Small-Cell Lung Cancer (NSCLC) stage IIIB with pleural effusion or stage IV\n* No prior systemic treatment for Non-Small-Cell Lung Cancer (NSCLC)with chemotherapy, immunotherapy, biologic response modifiers or other investigational drugs\n* Eastern Cooperative Oncology Performance Status (ECOG PS) 0 or 1\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Small cell or carcinoid lung cancer\n* Known Central Nervous System (CNS) metastasis\n* Pre-existing auto-immune or antibody mediated diseases",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Advanced Non-Small-Cell Lung Cancer (NSCLC) stage IIIB with pleural effusion or stage IV",
"criterions": [
{
"exact_snippets": "Advanced Non-Small-Cell Lung Cancer (NSCLC)",
"criterion": "Non-Small-Cell Lung Cancer (NSCLC)",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "advanced"
}
]
},
{
"exact_snippets": "stage IIIB with pleural effusion",
"criterion": "NSCLC stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IIIB"
},
{
"requirement_type": "condition",
"expected_value": "pleural effusion"
}
]
},
{
"exact_snippets": "stage IV",
"criterion": "NSCLC stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IV"
}
]
}
]
},
{
"line": "* Eastern Cooperative Oncology Performance Status (ECOG PS) 0 or 1",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Performance Status (ECOG PS) 0 or 1",
"criterion": "Eastern Cooperative Oncology Performance Status (ECOG PS)",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Small cell or carcinoid lung cancer",
"criterions": [
{
"exact_snippets": "Small cell ... lung cancer",
"criterion": "small cell lung cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "carcinoid lung cancer",
"criterion": "carcinoid lung cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Known Central Nervous System (CNS) metastasis",
"criterions": [
{
"exact_snippets": "Known Central Nervous System (CNS) metastasis",
"criterion": "Central Nervous System (CNS) metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pre-existing auto-immune or antibody mediated diseases",
"criterions": [
{
"exact_snippets": "Pre-existing auto-immune or antibody mediated diseases",
"criterion": "auto-immune diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Pre-existing auto-immune or antibody mediated diseases",
"criterion": "antibody mediated diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* No prior systemic treatment for Non-Small-Cell Lung Cancer (NSCLC)with chemotherapy, immunotherapy, biologic response modifiers or other investigational drugs",
"criterions": [
{
"exact_snippets": "No prior systemic treatment for Non-Small-Cell Lung Cancer (NSCLC) with chemotherapy",
"criterion": "prior systemic treatment with chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior systemic treatment for Non-Small-Cell Lung Cancer (NSCLC) with ... immunotherapy",
"criterion": "prior systemic treatment with immunotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior systemic treatment for Non-Small-Cell Lung Cancer (NSCLC) with ... biologic response modifiers",
"criterion": "prior systemic treatment with biologic response modifiers",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior systemic treatment for Non-Small-Cell Lung Cancer (NSCLC) with ... other investigational drugs",
"criterion": "prior systemic treatment with other investigational drugs",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}